The Relationship Between Mothers' Anxiety Levels and Hb-0 Vaccination among Infants in Kota Datar Village

Yulia Safitri, Nurhaida Br Kaban, Nopita Yanti Sitorus, Pratiwi Syah Putri

Abstract


 

Timely administration of the hepatitis B vaccine at birth (HB-0) is crucial to prevent mother-to-child transmission of the hepatitis B virus. However, HB-0 vaccination coverage, both globally and locally, remains below the desired level. Maternal concerns have been suggested as a potential barrier to newborn vaccination. This study aimed to evaluate the relationship between maternal anxiety levels and the use of HB-0 vaccination in infants in Kota Datar Village, located in Hamparan Perak District, Deli Serdang. In January and February 2024, a cross-sectional survey was conducted involving all mothers with infants aged 0–7 days (n = 35). Maternal anxiety was measured using the 20-item Zung Anxiety Scale. HB-0 vaccine acceptance was documented based on maternal statements and local government records. Chi-square analysis was used to test the relationship, with a significance level of α = 0.05. The group of 35 participants consisted mostly of people aged 20–35 years, and all had completed high school education. HB-0 was administered to 37.1% of infants (13 of 35). Conversely, 62.9% (22 of 35) did not receive HB-0 within the specified birth period. Maternal anxiety was a common problem, affecting 25 of 35 women. Mothers with severe anxiety were significantly less likely to administer HB-0 than those with mild anxiety (χ², p = 0.002). Survey responses, which included quantitative data, showed that safety concerns, fear of fever after vaccination, and misinformation were common reasons for concern. In this group, a significant association was found between maternal anxiety and reduced HB-0 acceptance. To improve the timely immunization of newborns against hepatitis B, it is recommended to use interventions that include prenatal counseling, focused information about risks, and increased involvement of frontline health workers. Future research should investigate the extent to which interventions to reduce anxiety affect vaccine acceptance.

 

Keywords:  Hepatitis B Birth Dose, HB-0 Immunization, Maternal Anxiety, Vaccine Uptake, Newborn Immunization.

Full Text:

PDF

References


Amalia, M., Yuwansyah, Y., & Awalia, R. N. (2021). Hubungan Tingkat Pengetahuan dan Tingkat Kecemasan Orang Tua terhadap Ketepatan Imunisasi Dasar Masa Covid-19. E-Journal STIKES YPIB Majalengka, 11(2), 190–203. https://doi.org/10.51171/jms.v11i2.308.

Badan Kebijakan Pembangunan Kesehatan. (2023). Survei Kesehatan Indonesia. Kementerian Kesehatan Republik Indonesia, 1–965. https://layanandata.kemkes.go.id/katalog-data/ski/ketersediaan-data/ski-2023.

Cheang, H. K., Wong, H. T., Ho, S. C., Chew, K. S., & Lee, W. S. (2013). Immune response in infants after universal hepatitis B vaccination: A community-based study in Malaysia. Singapore Medical Journal, 54(4), 224–226. https://doi.org/10.11622/smedj.2013078.

Hutasoit, D. M. (2025). Pengaruh Faktor Predisposisi , Pendukung , dan Penguat terhadap Pemberian Imunisasi HB-0 di Wilayah Kerja Puskesmas Bandar Baru Kecamatan Sibolangit Tahun 2025 Dessy Meilani Hutasoit Pentingnya imunisasi Hepatitis B perlu diketahui sebab penyakit hepatiti. Jurnal Riset Rumpun Ilmu Kesehatan, 3(1), 271–284.

Kartika, Y., Tambunan, L. N., & Lestari, R. M. (2022). Analisis Faktor yang Mempengaruhi Pemberian Imunisasi HB-0 pada Bayi Baru Lahir. Jurnal Surya Medika, 8(1), 156–160. https://doi.org/10.33084/jsm.v8i1.3459.

Klinger, G., Chodick, G., & Levy, I. (2018). Long-term immunity to hepatitis B following vaccination in infancy: Real-world data analysis. Vaccine, 36(17), 2288–2292. https://doi.org/10.1016/j.vaccine.2018.03.028.

Ma, J. C., Wu, Z. W., Zhou, H. S., Gao, Z., Hao, Z. Y., Jin, F., Zhang, Y. H., Li, M. J., Wang, F., Li, Q., Bi, S. L., & Zhao, Y. L. (2020). Long-term protection at 20–31 years after primary vaccination with plasma-derived hepatitis B vaccine in a Chinese rural community. Human Vaccines and Immunotherapeutics, 16(1), 16–20. https://doi.org/10.1080/21645515.2019.1646575.

Mutyoba, J. N., Surkan, P. J., Makumbi, F., Aizire, J., Kirk, G. D., Ocama, P., & Atuyambe, L. M. (2021). Corrigendum to “Hepatitis B birth dose vaccination for newborns in Uganda: A qualitative inquiry on pregnant women’s perceptions, barriers and preferences” [J Virus Eradic 7(2) (2021) 100039] (Journal of Virus Eradication (2021) 7(2), (S2055664021000121),. Journal of Virus Eradication, 7(3). https://doi.org/10.1016/j.jve.2021.100051.

Novika, R. G. H., Sriyanah, N., Sermoati, I. A., Agustini, M., & Shahab, F. (2024). Faktor-faktor yang Berhubungan dengan Kecemasan Ibu dalam Pemberian Imunisasi DPT pada Bayi. Encyclopedia of Journal, 6(3), 169–175.

Pattyn, J., Hendrickx, G., Vorsters, A., & Van Damme, P. (2021). Hepatitis B Vaccines. Journal of Infectious Diseases, 224(Suppl 4), S343–S351. https://doi.org/10.1093/infdis/jiaa668.

Phattraprayoon, N., Kakheaw, J., Soonklang, K., Cheirsilpa, K., Ungtrakul, T., Auewarakul, C., & Mahanonda, N. (2022). Duration of Hepatitis B Vaccine-Induced Protection among Medical Students and Healthcare Workers following Primary Vaccination in Infancy and Rate of Immunity Decline. Vaccines, 10(2), 1–9. https://doi.org/10.3390/vaccines10020267.

Pileggi, C., Papadopoli, R., Bianco, A., & Pavia, M. (2017). Hepatitis B vaccine and the need for a booster dose after primary vaccination. Vaccine, 35(46), 6302–6307. https://doi.org/10.1016/j.vaccine.2017.09.076.

Poovorawan, Y., Chongsrisawat, V., Theamboonlers, A., Crasta, P. D., Messier, M., & Hardt, K. (2013). Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: A 20-year follow-up study in Thailand. Human Vaccines and Immunotherapeutics, 9(8), 1679–1684. https://doi.org/10.4161/hv.24844.

Rosiska, M. (2022). Hubungan Tingkat Kecemasan Ibu yang Mempunyai Balita 12-14 Bulan dengan Pelaksanaan Imunisasi Dasar Lengkap Pada Masa Pendemi Covid 19 di Wilayah Kerja Puskesmas Koto Baru. Malahayati Nursing Journal, 4(3), 509–516. https://doi.org/10.33024/mnj.v4i3.5935.

Roznovsky, L., Orsagova, I., Kloudova, A., Tvrdik, J., Kabieszova, L., Lochman, I., Mrazek, J., Hozakova, L., Zjevikova, A., & Pliskova, L. (2010). Long-term protection against hepatitis B after newborn vaccination: 20-year follow-up. Infection, 38(5), 395–400. https://doi.org/10.1007/s15010-010-0039-7.

Safitri, D., Ningsih, F., & Ovany, R. (2023). Faktor yang Berhubungan dengan Pemberian Imunisasi HB 0 pada Bayi Baru Lahir di Puskesmas Kereng Bangkirai Factors Related to the Provision of HB 0 Immunization in Newborn Babies at Kereng Bangkirai Puskesmas. Jurnal Surya Medika, 9(1), 9–20.

Sidabutar, S., Friani, S., & Pasaribu, R. M. (2021). Factors Related to Giving Hb0 Immunization at Batu Anam Health Center, Simalungun. Health Notions, 5(4), 123–128. https://doi.org/https://doi.org/10.33846/hn50403.

Sukrisno, S., & Nadjib, M. (2022). Analisis Faktor-Faktor yang Berhubungan dengan Akses Imunisasi Hepatitis B 0-7 Hari (HB 0) pada Bayi Baru Lahir di Indonesia Tahun 2016. Media Kesehatan Masyarakat Indonesia, 21(4), 248–260. https://doi.org/10.14710/mkmi.21.4.248-260.

Van Der Sande, M. A. B., Waight, P., Mendy, M., Rayco-Solon, P., Hutt, P., Fulford, T., Doherty, C., McConkey, S. J., Jeffries, D., Hall, A. J., & Whittle, H. C. (2006). Long-term protection against carriage of hepatitis B virus after infant vaccination. Journal of Infectious Diseases, 193(11), 1528–1535. https://doi.org/10.1086/503433.

Wibowo, D. P., Chalid, M. T., Rasyak, M. R., El Khobar, K. E., Turyadi, Sjahril, R., Wahyuni, R., Setiady, Y., & Muljono, D. H. (2025). Characteristics of hepatitis B virus surface protein and occult hepatitis B infection in infants with immunoprophylaxis failure from Indonesia. Vaccine, 56(July 2024). https://doi.org/10.1016/j.vaccine.2025.127130.

World Health Organization. (2025). Immunization Coverage. World Health Organization.

Zakiyah, F., Setyowati, L., & Rohmati, H. (2024). Pengaruh Efek Samping Imunisasi terhadap Tingkat Kecemasan Ibu Balita. Oksitosin : Jurnal Ilmiah Kebidanan, 11(1), 64–72. https://doi.org/10.35316/oksitosin.v11i1.3936.

Zhao, H., Zhou, X., & Zhou, Y. H. (2020). Hepatitis B vaccine development and implementation. Human Vaccines and Immunotherapeutics, 16(7), 1533–1544. https://doi.org/10.1080/21645515.2020.1732166.




DOI: http://dx.doi.org/10.30829/contagion.v8i1.26911

Refbacks

  • There are currently no refbacks.


Copyright (c) 2026 Yulia Safitri, Nurhaida Br Kaban, Nopita Yanti Sitorus, Pratiwi Syah Putri

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Contagion: Scientific Periodical Journal of Public Health and Coastal Health by Program Studi Ilmu Kesehatan Masyarakat is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.